Thursday, September 24, 2015

The Pharmacogenomics Journal - Table of Contents alert Volume 15 Issue 5

If you are unable to see the message below, click here to view.
The Pharmacogenomics Journal


TABLE OF CONTENTS

Volume 15, Issue 5 (October 2015)

In this issue
Original Articles

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Submit your work to The Pharmacogenomics Journal

Covering multiple areas of medicine including cancer, cardiovascular, clinical immunology, precision & personalised medicine, The Pharmacogenomics Journal could be the place for your research. Reach an audience of over 77,000 with an Impact Factor of 4.229*.

*(2014 Journal Citation Reports® - Thomson Reuters, 2015)

Find out more: http://bit.ly/1W1vu5H
 
 

Original Articles

Top

Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate

S Jabeen, L Holmboe, G I G Alnæs, A M Andersen, K S Hall and V N Kristensen

Pharmacogenomics J 2015 15: 385-390; advance online publication, March 17, 2015; 10.1038/tpj.2015.11

Abstract | Full Text

LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy OPEN

J Szkandera, S Herzog, M Pichler, V Stiegelbauer, M Stotz, R Schaberl-Moser, H Samonigg, M Asslaber, S Lax, G Leitner, W Renner, H-J Lenz, A Berghold and A Gerger

Pharmacogenomics J 2015 15: 391-396; advance online publication, February 10, 2015; 10.1038/tpj.2015.2

Abstract | Full Text

Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy

L Paré-Brunet, A Sebio, J Salazar, A Berenguer-Llergo, E Río, A Barnadas, M Baiget and D Páez

Pharmacogenomics J 2015 15: 397-404; advance online publication, February 24, 2015; 10.1038/tpj.2015.1

Abstract | Full Text

Cytochrome P450 2J2, a new key enzyme in cyclophosphamide bioactivation and a potential biomarker for hematological malignancies

I El-Serafi, M Fares, M Abedi-Valugerdi, P Afsharian, A Moshfegh, Y Terelius, Z Potácová and M Hassan

Pharmacogenomics J 2015 15: 405-413; advance online publication, January 20, 2015; 10.1038/tpj.2014.82

Abstract | Full Text

Exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopurine producers

E W Chua, S Cree, M L Barclay, K Doudney, K Lehnert, A Aitchison and M A Kennedy

Pharmacogenomics J 2015 15: 414-421; advance online publication, March 10, 2015; 10.1038/tpj.2015.9

Abstract | Full Text

Pharmacodynamic genome-wide association study identifies new responsive loci for glucocorticoid intervention in asthma

Y Wang, C Tong, Z Wang, Z Wang, D Mauger, K G Tantisira, E Israel, S J Szefler, V M Chinchilli, H A Boushey, S C Lazarus, R F Lemanske and R Wu

Pharmacogenomics J 2015 15: 422-429; advance online publication, January 20, 2015; 10.1038/tpj.2014.83

Abstract | Full Text

The pharmacogenetics of codeine pain relief in the postpartum period

M Baber, S Chaudhry, L Kelly, C Ross, B Carleton, H Berger and G Koren

Pharmacogenomics J 2015 15: 430-435; advance online publication, March 10, 2015; 10.1038/tpj.2015.3

Abstract | Full Text

Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects

S Sadhasivam, X Zhang, V Chidambaran, J Mavi, V Pilipenko, T B Mersha, J Meller, K M Kaufman, L J Martin and J McAuliffe

Pharmacogenomics J 2015 15: 436-442; advance online publication, January 6, 2015; 10.1038/tpj.2014.79

Abstract | Full Text

Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes

C A Altar, J M Carhart, J D Allen, D K Hall-Flavin, B M Dechairo and J G Winner

Pharmacogenomics J 2015 15: 443-451; advance online publication, February 17, 2015; 10.1038/tpj.2014.85

Abstract | Full Text

Network analysis of gene expression in peripheral blood identifies mTOR and NF-κB pathways involved in antipsychotic-induced extrapyramidal symptoms

S Mas, P Gassó, E Parellada, M Bernardo and A Lafuente

Pharmacogenomics J 2015 15: 452-460; advance online publication, January 27, 2015; 10.1038/tpj.2014.84

Abstract | Full Text

Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis OPEN

M Verbelen, D A Collier, D Cohen, J H MacCabe and C M Lewis

Pharmacogenomics J 2015 15: 461-466; advance online publication, March 3, 2015; 10.1038/tpj.2015.5

Abstract | Full Text

Tag SNPs for HLA-B alleles that are associated with drug response and disease risk in the Chinese Han population

X Liu, J Sun, H Yu, H Chen, J Wang, H Zou, D Lu, J Xu and S L Zheng

Pharmacogenomics J 2015 15: 467-472; advance online publication, March 10, 2015; 10.1038/tpj.2015.7

Abstract | Full Text

Advertisement
Ensure your latest research is seen by publishing in Molecular Psychiatry!

Submit to the number 1 psychiatry journal for six years running! Molecular Psychiatry has an Impact Factor of 14.496* and over 70,000 people will see your paper in their inbox. MP prides itself on publishing comprehensive original articles and expert reviews.

*(2014 Journal Citation Reports® - Thomson Reuters, 2015)

Find out more: http://bit.ly/1W1tudG
 
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: